Johnson & Johnson halts mid-stage trial of experimental eczema drug - CNBC
Johnson & Johnson said it discontinued a mid-stage study of its experimental drug to treat atopic dermatitis, after it failed to meet efficacy goals.
Search Group
Share To
Comments
About Screade
Screade® Inc. version ec52223, copyright 2016 - 2026
Blocked Users
Customize Dark Theme
Forgot your password?
Forgot your password?
Invite your friends
Please type emails of people you want to invite, we will send them invitation email on your behalf. Separate emails with comma if you want to invite multiple friends.
Comments